Covered recipient · General Payments record
KEVIN PARZA
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2019–2024
$2,350.58
- Reported across 24 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,401.20 | 13 |
| Education | $339.92 | 4 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $243.60 | 2 |
| Acerta Pharma LLC | $207.23 | 2 |
| Exelixis Inc. | $174.94 | 2 |
| GENZYME CORPORATION | $164.43 | 2 |
| PFIZER INC. | $149.00 | 1 |
| Janssen Biotech, Inc. | $140.89 | 1 |
| JAZZ PHARMACEUTICALS INC. | $123.12 | 1 |
| Gilead Sciences, Inc. | $114.75 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $99.56 | 1 |
| Amgen Inc. | $91.29 | 1 |
| SEAGEN INC. | $89.99 | 1 |
| Astellas Pharma US Inc | $74.99 | 1 |
| GlaxoSmithKline, LLC. | $67.33 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $91.29 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117649592 | CMS |
| Astellas Pharma US Inc | $74.99 | 10/08/2024 | Education | Undisputed | 01/23/2026 | 1139419639 | CMS |
| AstraZeneca Pharmaceuticals LP | $122.44 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105548207 | CMS |
| AstraZeneca Pharmaceuticals LP | $84.79 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105381076 | CMS |
| E.R. Squibb & Sons, L.L.C. | $120.87 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101755113 | CMS |
| E.R. Squibb & Sons, L.L.C. | $122.73 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101755156 | CMS |
| Exelixis Inc. | $99.95 | 05/15/2024 | Education | Undisputed | 01/23/2026 | 1138560592 | CMS |
| Exelixis Inc. | $74.99 | 08/30/2024 | Education | Undisputed | 01/23/2026 | 1138560594 | CMS |
| GENZYME CORPORATION | $68.33 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139781619 | CMS |
| GENZYME CORPORATION | $96.10 | 12/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139781689 | CMS |
| Gilead Sciences, Inc. | $114.75 | 05/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133637881 | CMS |
| GlaxoSmithKline, LLC. | $67.33 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116244434 | CMS |
| Janssen Biotech, Inc. | $140.89 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078492697 | CMS |
| JAZZ PHARMACEUTICALS INC. | $123.12 | 12/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150205658 | CMS |
| Novartis Pharmaceuticals Corporation | $99.56 | 12/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087343289 | CMS |
| PFIZER INC. | $149.00 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131338541 | CMS |
| SEAGEN INC. | $89.99 | 10/29/2024 | Education | Undisputed | 01/23/2026 | 1131995069 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.